TrialSignal transduction and targeted therapy2024

Anlotinib plus chemotherapy as a first-line treatment for gastrointestinal cancer patients with unresectable liver metastases: a multicohort, multicenter, exploratory trial.

Jun-Wei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.